Robert Stefanovich - Cryoport CFO, Treasurer, Corporate Secretary
| CYRX Stock | USD 7.78 0.70 9.89% |
CFO
Mr. Robert S. Stefanovich is the Chief Financial Officer, Treasurer, Corporationrationrate Secretary of the Company. Mr. Stefanovich became Chief Financial Officer, Treasurer and Corporationrationrate Secretary for the Company in June 2011. From June 15, 2012 to November 4, 2012, Mr. Stefanovich served as the Principal Executive Officer of the Company. From November 2007 through March 2011, Mr. Stefanovich served as Chief Financial Officer of Novalar Pharmaceuticals, Inc., a venturebacked specialty pharmaceutical company. Prior to that, he held several senior positions, including interim Chief Financial Officer of Xcorporeal, Inc., a publicly traded medical device company, Executive Vice President and Chief Financial Officer of Artemis International Solutions Corporationrationration, a publicly traded software company, Chief Financial Officer and Secretary of Aethlon Medical Inc., a publicly traded medical device company and Vice President of Administration at SAIC, a Fortune 500 company since 2018.
| Age | 59 |
| Tenure | 6 years |
| Address | 112 Westwood Place, Brentwood, TN, United States, 37027 |
| Phone | 949 470 2300 |
| Web | https://www.cryoportinc.com |
Latest Insider Transactions
Stefanovich also served as a member of the Software Advisory Group and an Audit Manager with Price Waterhouse LLP’s hitech practice in San Jose, CA and Frankfurt, Germany. He currently also serves as a board member of Project InVision International, a provider of business performance improvement solutions. He received his Masters of Business Administration and Engineering from University of Darmstadt, Germany.Robert Stefanovich Latest Insider Activity
Tracking and analyzing the buying and selling activities of Robert Stefanovich against Cryoport stock is an integral part of due diligence when investing in Cryoport. Robert Stefanovich insider activity provides valuable insight into whether Cryoport is net buyers or sellers over its current business cycle. Note, Cryoport insiders must abide by specific rules, including filing SEC forms every time they buy or sell Cryoport'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Robert Stefanovich over a year ago Exercise or conversion by Robert Stefanovich of 16000 shares of Cryoport subject to Rule 16b-3 | ||
Robert Stefanovich over a year ago Exercise or conversion by Robert Stefanovich of 19918 shares of Cryoport subject to Rule 16b-3 | ||
Robert Stefanovich over a year ago Acquisition by Robert Stefanovich of 10455 shares of Cryoport subject to Rule 16b-3 | ||
Robert Stefanovich over a year ago Sale by Robert Stefanovich of 1069 shares of Cryoport |
Cryoport Management Efficiency
The company has return on total asset (ROA) of (0.0512) % which means that it has lost $0.0512 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.3315) %, meaning that it created substantial loss on money invested by shareholders. Cryoport's management efficiency ratios could be used to measure how well Cryoport manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -0.16 in 2024. Return On Capital Employed is likely to rise to -0.12 in 2024. At this time, Cryoport's Total Assets are fairly stable compared to the past year. Non Current Assets Total is likely to rise to about 443.8 M in 2024, whereas Other Assets are likely to drop 0.95 in 2024.Similar Executives
| Found 2 records | CFO Age | ||
| Roderick Greef | BioLife Solutions | 64 | |
| Abhishek Jain | Caredx Inc | 48 | |
Management Performance
| Return On Equity | -0.33 | ||||
| Return On Asset | -0.0512 |
Cryoport Leadership Team
Elected by the shareholders, the Cryoport's board of directors comprises two types of representatives: Cryoport inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Cryoport. The board's role is to monitor Cryoport's management team and ensure that shareholders' interests are well served. Cryoport's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Cryoport's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Robert Stefanovich, CFO, Treasurer, Corporate Secretary | ||
| Thomas Heinzen, Vice Relations | ||
| Robert MS, CFO Treasurer | ||
| Tony Ippolito, VP Counsel | ||
| Phil Wilson, LLC Systems | ||
| Jerrell Shelton, CEO and President and Director | ||
| Edward Zecchini, Senior Officer | ||
| Mark Sawicki, Chief Officer | ||
| Raymond MD, Ex Officer | ||
| Bret Bollinger, LLC Systems | ||
| David MD, Ex Officer | ||
| Kylie Crowe, Vice Development |
Cryoport Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Cryoport a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.33 | ||||
| Return On Asset | -0.0512 | ||||
| Profit Margin | (0.70) % | ||||
| Operating Margin | (0.27) % | ||||
| Current Valuation | 377.54 M | ||||
| Shares Outstanding | 49.43 M | ||||
| Shares Owned By Insiders | 2.58 % | ||||
| Shares Owned By Institutions | 97.42 % | ||||
| Number Of Shares Shorted | 2.7 M | ||||
| Price To Earning | (13.39) X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Cryoport Stock Analysis
When running Cryoport's price analysis, check to measure Cryoport's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cryoport is operating at the current time. Most of Cryoport's value examination focuses on studying past and present price action to predict the probability of Cryoport's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cryoport's price. Additionally, you may evaluate how the addition of Cryoport to your portfolios can decrease your overall portfolio volatility.